SREBF1 and Insulin resistance: Recently, Wang et al. (2019) reported that FOXO3 promotes the transcriptional activity of the SREBP1c promoter, thus leading to increased TG synthesis and hepatic TG accumulation in the high glucose and high PA-induced HepG2 cells and the obese mice under insulin resistance.